• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.前列腺干细胞区室:细胞周期抑制剂p27Kip1在正常、增生和肿瘤细胞中的表达
Am J Pathol. 1998 Sep;153(3):911-9. doi: 10.1016/S0002-9440(10)65632-5.
2
Levels of expression of p27KIP1 protein in human prostate and prostate cancer: an immunohistochemical analysis.p27KIP1蛋白在人前列腺及前列腺癌中的表达水平:一项免疫组织化学分析
Mod Pathol. 1999 Aug;12(8):751-5.
3
Expression of p27/Kip1 is down-regulated in human prostate carcinoma progression.在人类前列腺癌进展过程中,p27/Kip1的表达下调。
J Pathol. 1999 Apr;187(5):563-6. doi: 10.1002/(SICI)1096-9896(199904)187:5<563::AID-PATH292>3.0.CO;2-3.
4
Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.人良性、癌前和恶性前列腺组织中细胞凋亡发生率以及p53、转化生长因子-β受体II、p27Kip1和Smad4的蛋白表达
Hum Pathol. 2004 Mar;35(3):290-7. doi: 10.1016/j.humpath.2003.11.001.
5
Stem cell features of benign and malignant prostate epithelial cells.良性和恶性前列腺上皮细胞的干细胞特征
J Urol. 1998 Dec;160(6 Pt 2):2381-92. doi: 10.1097/00005392-199812020-00004.
6
Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis.前列腺增生性炎性萎缩:对前列腺癌发生的影响
Am J Pathol. 1999 Dec;155(6):1985-92. doi: 10.1016/S0002-9440(10)65517-4.
7
Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma.良性前列腺增生和前列腺癌中p27KIP1基因表达的不同改变模式。
J Natl Cancer Inst. 1998 Sep 2;90(17):1284-91. doi: 10.1093/jnci/90.17.1284.
8
Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.细胞周期蛋白依赖性激酶抑制剂p27(Kip1)蛋白在人类前列腺癌中的缺失与肿瘤分级相关。
Clin Cancer Res. 1997 Dec;3(12 Pt 1):2269-74.
9
Expression of p27kip1 in prostatic adenocarcinoma.p27kip1在前列腺腺癌中的表达。
Mod Pathol. 1998 Apr;11(4):324-8.
10
Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.去势雄激素条件下LNCaP前列腺肿瘤细胞的进展:激素非依赖性生长、雄激素对增殖的抑制以及p27Kip1在雄激素诱导的细胞周期阻滞中的作用
Mol Endocrinol. 1998 Jul;12(7):941-53. doi: 10.1210/mend.12.7.0136.

引用本文的文献

1
SOX2 utilizes FOXA1 as a heteromeric transcriptional partner to drive proliferation in therapy-resistant prostate cancer.SOX2利用FOXA1作为异源转录伙伴来驱动去势抵抗性前列腺癌的增殖。
bioRxiv. 2025 Jul 19:2025.07.18.664790. doi: 10.1101/2025.07.18.664790.
2
The Homeobox Transcription Factor NKX3.1 Displays an Oncogenic Role in Castration-Resistant Prostate Cancer Cells.同源框转录因子NKX3.1在去势抵抗性前列腺癌细胞中发挥致癌作用。
Cancers (Basel). 2025 Jan 18;17(2):306. doi: 10.3390/cancers17020306.
3
Therapeutic implications of cancer stem cells in prostate cancer.癌症干细胞在前列腺癌中的治疗意义。
Cancer Biol Med. 2023 Jun 5;20(6):401-20. doi: 10.20892/j.issn.2095-3941.2022.0714.
4
The most effective but largely ignored target for prostate cancer early detection and intervention.前列腺癌早期检测和干预最有效但在很大程度上被忽视的靶点。
J Cancer. 2022 Oct 17;13(13):3463-3475. doi: 10.7150/jca.72973. eCollection 2022.
5
Genomic Characterization of Prostatic Basal Cell Carcinoma.前列腺基底细胞癌的基因组特征。
Am J Pathol. 2023 Jan;193(1):4-10. doi: 10.1016/j.ajpath.2022.09.010. Epub 2022 Oct 26.
6
Tracing TET1 expression in prostate cancer: discovery of malignant cells with a distinct oncogenic signature.追踪前列腺癌中的 TET1 表达:发现具有明显致癌特征的恶性细胞。
Clin Epigenetics. 2021 Nov 29;13(1):211. doi: 10.1186/s13148-021-01201-7.
7
PUM1 represses CDKN1B translation and contributes to prostate cancer progression.PUM1抑制CDKN1B的翻译并促进前列腺癌进展。
J Biomed Res. 2021 Jul 16;35(5):371-382. doi: 10.7555/JBR.35.20210067.
8
Non-Coding RNAs Set a New Phenotypic Frontier in Prostate Cancer Metastasis and Resistance.非编码 RNA 在前列腺癌转移和耐药中开辟了新的表型前沿。
Int J Mol Sci. 2021 Feb 20;22(4):2100. doi: 10.3390/ijms22042100.
9
Olfactomedin 4 mediation of prostate stem/progenitor-like cell proliferation and differentiation via MYC.嗅鞘蛋白 4 通过 MYC 介导前列腺干/祖细胞样细胞的增殖和分化。
Sci Rep. 2020 Dec 14;10(1):21924. doi: 10.1038/s41598-020-78774-5.
10
Functional and Mechanistic Interrogation of BET Bromodomain Degraders for the Treatment of Metastatic Castration-resistant Prostate Cancer.用于治疗转移性去势抵抗性前列腺癌的BET溴结构域降解剂的功能与作用机制研究
Clin Cancer Res. 2019 Jul 1;25(13):4038-4048. doi: 10.1158/1078-0432.CCR-18-3776. Epub 2019 Mar 27.

本文引用的文献

1
Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.细胞周期蛋白依赖性激酶抑制剂p27(Kip1)蛋白在人类前列腺癌中的缺失与肿瘤分级相关。
Clin Cancer Res. 1997 Dec;3(12 Pt 1):2269-74.
2
Identification of intermediate cell types by keratin expression in the developing human prostate.通过角蛋白表达鉴定发育中的人类前列腺中的中间细胞类型。
Prostate. 1998 Mar 1;34(4):292-301. doi: 10.1002/(sici)1097-0045(19980301)34:4<292::aid-pros7>3.0.co;2-j.
3
Relation between Bcl-2, cell proliferation, and the androgen receptor status in prostate tissue and precursors of prostate cancer.前列腺组织及前列腺癌前体中Bcl-2、细胞增殖与雄激素受体状态之间的关系。
Prostate. 1998 Mar 1;34(4):251-8. doi: 10.1002/(sici)1097-0045(19980301)34:4<251::aid-pros2>3.0.co;2-k.
4
Novel nuclear phosphoprotein pp32 is highly expressed in intermediate- and high-grade prostate cancer.新型核磷蛋白pp32在中高级前列腺癌中高表达。
Prostate. 1998 Feb 15;34(3):231-7. doi: 10.1002/(sici)1097-0045(19980215)34:3<231::aid-pros11>3.0.co;2-f.
5
Low p27 expression predicts poor disease-free survival in patients with prostate cancer.低水平的p27表达预示着前列腺癌患者无病生存期较差。
J Urol. 1998 Mar;159(3):941-5.
6
Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma.细胞周期蛋白依赖性激酶抑制剂p27Kip1的缺失是局限性人类前列腺腺癌的一种新的预后因素。
Cancer Res. 1998 Feb 1;58(3):542-8.
7
Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas.细胞周期蛋白依赖性激酶抑制剂p27Kip1的表达降低与胃癌的晚期阶段和侵袭性相关。
Jpn J Cancer Res. 1997 Jul;88(7):625-9. doi: 10.1111/j.1349-7006.1997.tb00428.x.
8
Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer.细胞周期蛋白依赖性激酶抑制剂p27在非小细胞肺癌中的预后作用。
Cancer Res. 1997 Aug 15;57(16):3381-5.
9
Cyclin-dependent kinase inhibitor p27KIP1 in lymphoid tissue: p27KIP1 expression is inversely proportional to the proliferative index.细胞周期蛋白依赖性激酶抑制剂p27KIP1在淋巴组织中的作用:p27KIP1表达与增殖指数呈负相关。
Am J Pathol. 1997 Jul;151(1):151-60.
10
Differentiation of rat neonatal ventral prostates grown in a serum-free organ culture system.在无血清器官培养系统中生长的大鼠新生腹侧前列腺的分化
Prostate. 1997 Jun 15;32(1):35-42. doi: 10.1002/(sici)1097-0045(19970615)32:1<35::aid-pros5>3.0.co;2-b.

前列腺干细胞区室:细胞周期抑制剂p27Kip1在正常、增生和肿瘤细胞中的表达

Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.

作者信息

De Marzo A M, Meeker A K, Epstein J I, Coffey D S

机构信息

Department of Pathology and The James Buchanan Brady Urological Institute, The Johns Hopkins University Medical Institutions, Baltimore, Maryland 21287-2101, USA.

出版信息

Am J Pathol. 1998 Sep;153(3):911-9. doi: 10.1016/S0002-9440(10)65632-5.

DOI:10.1016/S0002-9440(10)65632-5
PMID:9736039
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1853003/
Abstract

The stem cells of rapidly renewing tissues give rise to transiently proliferating cells, which in turn give rise to postmitotic terminally differentiated cells. Although the existence of a transiently proliferating compartment has been proposed for the prostate, little molecular anatomical evidence for its presence has been obtained to date. We used down-regulation of the cyclin-dependent kinase inhibitor p27Kip1 to identify cells capable of entering the proliferative phase of the cell cycle and, therefore, competent to fulfill the role of the transiently proliferating compartment. We examined the expression of p27Kip1 in relation to its role in the development of prostatic carcinoma. Formalin-fixed paraffin-embedded specimens from matched samples of normal-appearing prostate tissue, benign prostatic hyperplasia, high-grade prostatic intraepithelial neoplasia, primary adenocarcinomas, and pelvic lymph node metastases were evaluated by comparative immunohistochemistry against p27Kip1. In normal-appearing prostate epithelium, moderate to strong nuclear staining of p27Kip1 was present in greater than 85% of the terminally differentiated secretory cells. The normal basal cell compartment, believed to contain prostatic stem cells, showed distinctive p27Kip1 expression; acini in epithelial benign prostatic hyperplasia tissue contained more p27Kip1-negative basal cells than acini from non-benign prostatic hyperplasia tissue. A third layer of cells was identified that was sandwiched between the basal cells and the luminal cells, and this layer was consistently p27Kip1 negative. This intermediate layer was accentuated in the periurethral region, as well as in prostate tissue that had been subjected to prior combined androgen blockade. We hypothesize that, on appropriate additional mitogenic stimulation, cells in this layer, and other p27Kip1-negative basal cells, are competent for rapid entry into the cell cycle. Consistent with the fact that cancer cells are capable of cell division, all cases of high-grade prostatic intraepithelial neoplasia and invasive carcinoma also showed down-regulation of p27Kip1 as compared with the surrounding normal-appearing secretory cells. In pelvic lymph node metastases, p27Kip1 expression was also reduced. In summary, our results suggest that lack of nuclear p27Kip1 protein may delineate a potential transiently proliferating subcompartment within the basal cell compartment of the human prostate. In addition, these studies support the hypothesis that reduced expression of p27Kip1 removes a block to the cell cycle in human prostate epithelial cells and that dysregulation of p27Kip1 protein levels may be a critical early event in the development of prostatic neoplasia.

摘要

快速更新组织的干细胞会产生短暂增殖细胞,而短暂增殖细胞又会产生有丝分裂后终末分化细胞。尽管有人提出前列腺存在短暂增殖区室,但迄今为止,几乎没有获得其存在的分子解剖学证据。我们通过下调细胞周期蛋白依赖性激酶抑制剂p27Kip1来识别能够进入细胞周期增殖期的细胞,因此能够充当短暂增殖区室的角色。我们研究了p27Kip1的表达及其在前列腺癌发生发展中的作用。通过针对p27Kip1的比较免疫组织化学方法,对外观正常的前列腺组织、良性前列腺增生、高级别前列腺上皮内瘤变、原发性腺癌和盆腔淋巴结转移的匹配样本的福尔马林固定石蜡包埋标本进行了评估。在外观正常的前列腺上皮中,超过85%的终末分化分泌细胞呈现中度至强的p27Kip1核染色。被认为含有前列腺干细胞的正常基底细胞区室显示出独特的p27Kip1表达;上皮性良性前列腺增生组织中的腺泡比非良性前列腺增生组织中的腺泡含有更多p27Kip1阴性的基底细胞。识别出了夹在基底细胞和管腔细胞之间的第三层细胞,这一层始终为p27Kip1阴性。这一中间层在尿道周围区域以及先前接受过联合雄激素阻断的前列腺组织中更为明显。我们推测,在适当的额外促有丝分裂刺激下,这一层中的细胞以及其他p27Kip1阴性的基底细胞能够迅速进入细胞周期。与癌细胞能够进行细胞分裂这一事实一致,与周围外观正常的分泌细胞相比,所有高级别前列腺上皮内瘤变和浸润性癌病例也显示出p27Kip1的下调。在盆腔淋巴结转移中,p27Kip1表达也降低。总之,我们的结果表明,缺乏核p27Kip1蛋白可能界定了人类前列腺基底细胞区室内一个潜在的短暂增殖亚区室。此外,这些研究支持这样的假说,即p27Kip1表达降低消除了人类前列腺上皮细胞中细胞周期的阻滞,并且p27Kip1蛋白水平的失调可能是前列腺肿瘤发生发展中的一个关键早期事件。